In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.
The state of the Asia-Pacific PR industry (Ep. 159)
To pod or not to pod? (Ep. 158)
Redhill's Jacob Puthenparambil (Ep. 157)
Australia's History will be Kind & Poem (Ep. 156)
Firehouse Strategies (Ep. 155)
UN Spokesperson Stéphane Dujarric (Ep. 154)
The Academy's Mitch Kaye & Dan Glover (Ep. 153)
Closing the Gap on PR's Challenge (ep. 152)
Asda'a BCW's Sunil John on the PR industry's evolution in MENA (Ep. 151)
Davos Dialogues with Ketchum's Barri Rafferty (Ep. 150)
Podcast: Ketchum London's Jo-ann Robertson (Ep. 149)
Super Bowl LIII marketing & engagement review (Ep. 148)
Podcast: What makes kids tick? With Therese Caruso (Ep. 147)
Davos Voices: Senior marketers & comms leaders at #wef19 (Ep. 146)
Hotwire CEO Barbara Bates (Ep. 145)
2019 predictions with Alan VanderMolen (Ep. 144)
Rethinking Innovation & Analytics with Bulleit Group, Proof (Ep. 143)
Sir Martin Sorrell (Ep. 142)
Tim Sutton turns the tables (Ep. 141)
David Ko on 'deepfake content' and cybersecurity in China (Ep. 140)
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money